REVELATION BIOSCIENCES, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that REVELATION BIOSCIENCES, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($1.91M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.44M) | Aug 8, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($2.44M) | Nov 6, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($2.05M) | Aug 8, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($2.05M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($2.05M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($2.24M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($8.39M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($8.39M) | Aug 8, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($2.68M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($2.68M) | May 8, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($2.68M) | Aug 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.63M) | Nov 8, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.45M) | Sep 23, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($1.45M) | Nov 8, 2024 |
| Q3 | 2024 | Mar 31, 2023 | $6.16M | Nov 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $6.16M | Sep 23, 2024 |
| Q2 | 2024 | Mar 31, 2023 | $6.16M | Sep 23, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.17M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.83M) | Aug 11, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($1.94M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($2.46M) | Aug 8, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($2.09M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($1.80M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($2.52M) | Aug 8, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($1.90M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($2.78M) | Nov 8, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.93M) | Sep 23, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.62M) | Sep 23, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.20M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.86M) | Aug 11, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($6.59M) | May 22, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($3.04M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($2.44M) | Aug 15, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($2.61M) | May 16, 2022 |